179 related articles for article (PubMed ID: 12586054)
1. Return of the chalones.
Gamer LW; Nove J; Rosen V
Dev Cell; 2003 Feb; 4(2):143-4. PubMed ID: 12586054
[TBL] [Abstract][Full Text] [Related]
2. Myostatin and the control of skeletal muscle mass.
Lee SJ; McPherron AC
Curr Opin Genet Dev; 1999 Oct; 9(5):604-7. PubMed ID: 10508689
[TBL] [Abstract][Full Text] [Related]
3. Chalones revisited--a possible role for transforming growth factor beta in tumour promotion.
Parkinson K; Balmain A
Carcinogenesis; 1990 Feb; 11(2):195-8. PubMed ID: 2137380
[No Abstract] [Full Text] [Related]
4. [Negative regulators of cell growth].
Liu Y; Tong TJ
Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):26-9. PubMed ID: 1384121
[No Abstract] [Full Text] [Related]
5. TGFβ Superfamily Members as Regulators of B Cell Development and Function-Implications for Autoimmunity.
Tamayo E; Alvarez P; Merino R
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544541
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta.
Massagué J; Cheifetz S; Laiho M; Ralph DA; Weis FM; Zentella A
Cancer Surv; 1992; 12():81-103. PubMed ID: 1638549
[TBL] [Abstract][Full Text] [Related]
7. [Tissue-specific regulation of proliferative processes in the tissues normally and in pathology: on the problem of chalones].
Ketlinskiĭ SA
Arkh Patol; 1978; 40(3):3-13. PubMed ID: 148259
[TBL] [Abstract][Full Text] [Related]
8. Growth restrictions in the regulation of haemopoiesis.
Zipori D; Honigwachs-Sha'anani J
Baillieres Clin Haematol; 1992 Jul; 5(3):741-52. PubMed ID: 1457967
[No Abstract] [Full Text] [Related]
9. [Chalones. Endogenous inhibitors of cell division?].
Paukovits WR
Blut; 1973 Oct; 27(4):217-22. PubMed ID: 4275334
[No Abstract] [Full Text] [Related]
10. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
Levine AE; Lewis LR
Cancer Lett; 1993 Jan; 68(1):33-41. PubMed ID: 8422647
[TBL] [Abstract][Full Text] [Related]
11. The TGFβ superfamily in cardiac dysfunction.
Wu J; Jackson-Weaver O; Xu J
Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):323-335. PubMed ID: 29462261
[TBL] [Abstract][Full Text] [Related]
12. Tissue specificity of the epidermal chalones.
Nome O
Virchows Arch B Cell Pathol; 1975 Sep; 19(1):1-25. PubMed ID: 126520
[TBL] [Abstract][Full Text] [Related]
13. [Chalones as factors in tissue homeostasis].
Ketlinskiĭ SA
Arkh Anat Gistol Embriol; 1980 Jan; 78(1):29-49. PubMed ID: 6446270
[No Abstract] [Full Text] [Related]
14. Chalones: concepts and results.
Rytömaa T; Toivonen H
Mech Ageing Dev; 1979 Mar; 9(5-6):471-80. PubMed ID: 156827
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta--mullerian inhibiting substance family of growth regulators.
Liu MA; Oliff A
Cancer Invest; 1991; 9(3):325-36. PubMed ID: 1913235
[No Abstract] [Full Text] [Related]
16. Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.
Classen S; Zander T; Eggle D; Chemnitz JM; Brors B; Büchmann I; Popov A; Beyer M; Eils R; Debey S; Schultze JL
J Immunol; 2007 Jun; 178(11):6931-40. PubMed ID: 17513742
[TBL] [Abstract][Full Text] [Related]
17. In vitro assays for measuring TGF-beta growth stimulation and inhibition.
Edens M; Leof EB
Methods Mol Biol; 2000; 142():1-11. PubMed ID: 10806609
[No Abstract] [Full Text] [Related]
18. Deregulated expression of cyclin D1 overrides antimitogenic signals.
Martinez LA; Chen Y; Pavone A; Fischer SM; Conti CJ
Oncogene; 2000 Jan; 19(2):315-22. PubMed ID: 10645011
[TBL] [Abstract][Full Text] [Related]
19. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
Fynan TM; Reiss M
Crit Rev Oncog; 1993; 4(5):493-540. PubMed ID: 8241322
[TBL] [Abstract][Full Text] [Related]
20. [Significance of chalones (Bullough) for epidermal regulation].
Schaefer H
Arch Dermatol Forsch; 1972; 244():52-4. PubMed ID: 4265233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
